Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE (ABBV)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is one of the best yield companies with high dividend expectations.
  • The stock is in a well-established, long-term rising trend above the technical support level at 69.96 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 91.2.
  • Technically, the stock approaches a strong medium-term resistance at USD 92.38.
  • The company is in debt and has limited leeway for investment
  • The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalisation (M$)Investor Rating
ABBVIE44.79%144 537
MERCK KGAA-2.83%14 717
KYOWA HAKKO KIRIN CO LTD23.05%10 210
JAZZ PHARMACEUTICALS PLC29.67%8 492
CONVATEC GROUP19.41%7 227
ZHANGZHOU PIENTZEHUANG PHAR..29.42%5 435
BETTA PHARMACEUTICALS CO LT..--.--%3 645
MALLINCKRODT PLC-33.18%3 235
INDIVIOR13.40%3 213
ADVANCED ACCELERATOR APPLIC..--.--%3 019
YUHAN CORP--.--%2 119
SUPERNUS PHARMACEUTICALS IN..63.76%2 096
REPLIGEN CORPORATION24.92%1 675
AIMMUNE THERAPEUTICS INC22.79%1 269
STALLERGENES GREER47.38%1 065
-
KNIGHT THERAPEUTICS INC-18.22%1 003
More Results
Financials ($)
Sales 2017 27 978 M
EBIT 2017 11 934 M
Net income 2017 7 394 M
Debt 2017 25 874 M
Yield 2017 2,86%
P/E ratio 2017 19,45
P/E ratio 2018 15,69
EV / Sales 2017 6,09x
EV / Sales 2018 5,39x
Capitalization 145 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart ABBVIE
Duration : Period : Day
AbbVie Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Duration : Period : Week
AbbVie Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders